Last updated: June 11, 2026

Back to directory

Nanox.AI HealthCCSng medical AI product profile

FDA-cleared cardiac AI solution that analyzes routine chest CTs for coronary artery calcium and returns calcium scoring or detection-category outputs for clinician review.

Screenshot of the official Nanox.AI HealthCCSng product page
Medical imaging and radiology

Best fit

Imaging programs that want opportunistic cardiovascular risk detection from existing CT studies while preserving radiologist review, cardiology follow-up, and local preventive-care protocols.

Primary use case
FDA-cleared AI post-processing of routine non-gated, non-contrast CT studies to identify coronary artery calcium and add CAC scoring or category output to radiology and follow-up workflows
Audience
Radiology groups, imaging centers, health systems, cardiology programs, preventive-care teams, population-health leaders, and CT workflow owners
Risk level
High
Pricing signal
Public pages emphasize ROI and cardiology revenue but do not publish contract pricing; verify current software version, deployment, PACS/EMR integration, support, privacy, reimbursement, and service terms.
Official sources
4 official sources

Compare within workflow: Medical imaging and radiology · comparison shortlist · source index

Regulatory, privacy, evidence, and workflow lens

Product-specific review. These product-specific signals summarize what the cited sources imply before treating Nanox.AI HealthCCSng as safe for a local clinical, operational, or research workflow.

Regulatory / FDATreat as regulated radiological post-processing software; match use to the exact cleared HealthCCSng version, patient age, CT study type, output type, radiologist review boundary, and non-standalone decision language.
PrivacyReview DICOM routing, cloud processing, PACS and EMR interfaces, PHI and metadata retention, support access, audit logging, cybersecurity materials, BAA terms, and model-update governance before routing production scans.
EvidenceValidate against local CT protocols, scanner vendors, calcium prevalence, radiology reporting patterns, cardiology follow-up capacity, false-positive burden, missed disease, and patient outcomes rather than relying only on clearance or vendor case studies.
WorkflowBest governed as opportunistic imaging detection feeding radiologist-reviewed reports and predefined cardiovascular follow-up pathways, with ownership across radiology, cardiology, primary care, quality, privacy, and IT.

Where Nanox.AI HealthCCSng fits

Nanox describes its AI Cardiac Solution as FDA 510(k)-cleared and CE-marked software that analyzes routine non-contrast, non-ECG-gated chest CT scans, measures and visualizes coronary calcified plaque, and integrates output into radiology reports and EMR systems. FDA 510(k) K241440 describes HealthCCSng as post-processing software for routine non-gated, non-contrast CT studies that include the entire heart in adults age 30 to 85, and states results are not intended for standalone risk attribution or clinical decision-making.

Not for: Standalone coronary risk attribution, autonomous clinical decision-making, diagnosis without clinician assessment, unsupported CT protocols, patients outside the cleared age and study scope, or deployments without CAC follow-up governance.

What to verify before using Nanox.AI HealthCCSng

Source links

Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.

Related medical AI products